Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00453258 · ClinicalTrials.gov registry record
Pilot Study of Human Tear Proteins
A clinical trial, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- 63
- Enrollment target
NCT00453258: Clinical Trial study, sponsored by University of Colorado, Denver.
NCT00453258 is a clinical trial that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 63 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00453258 was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- 63 participants
- Enrollment target
Study Summary
The significance of our study is in the importance of understanding the quality and quantity of proteins in the human tear film from diseased and non-diseased patients. This pilot study will provide data to plan prospective research to better delineate the utility of tear proteins in diagnosing and following disease status in a non-invasive fashion.
Primary Outcome
Pilot study will provide data to plan prospective research to better delineate the utility of tear proteins in diagnosing and following disease status in a non-invasive fashion.
Interventions
- OTHER Eye Examination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2007-02 |
| Est. Completion | 2011-09 |
Why NCT00453258 stopped before completion
NCT00453258 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 63 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Eye Examination is the first listed.
NCT00453258 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00453258 about?
NCT00453258 is a clinical study titled "Pilot Study of Human Tear Proteins". The significance of our study is in the importance of understanding the quality and quantity of proteins in the human tear film from diseased and non-diseased patients. This pilot study will provide data to plan prospective research to better delineate the utility of tear proteins in diagnosing and ...
What is the current status of trial NCT00453258?
This trial is currently terminated. The enrollment target is 63 participants. The study started on 2007-02. Estimated completion is 2011-09.
What interventions are being tested in trial NCT00453258?
The interventions under investigation include: Eye Examination (OTHER).
Who is sponsoring clinical trial NCT00453258?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia